Ads

 

Ads

 

Ads

 

World Top 100 HealthCare Products Companies List by Market Cap in January 2024

World Top 100 HealthCare Products Companies List by Market Cap in January 2024, World Biggest 100 HealthCare Products Companies by Market Cap, World Largest 100 HealthCare Products Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Largest HealthCare Products Companies in 2024
Metatag Abstract
World Top HealthCare Products Companies by Market Cap in 2024, World Largest HealthCare Products Companies by Market Cap in 2024.
  1. Editas Medicine

    World Rank (Jan-05-2024)
    9,928
    Market Cap (Jan-05-2024)
    0.779 Billion USD
    World Rank (Jul-30-2023)
    10,632
    Market Cap (Jul-30-2023)
    0.707 Billion USD
    World Rank (Dec-25-2022)
    11,186
    Market Cap (Dec-25-2022)
    0.608 Billion USD
    World Rank (Jan-07-2022)
    6,883
    Market Cap (Jan-07-2022)
    1.72 Billion USD
    Annual Revenue in USD
    20 Million USD
    Annual Operating Income in USD
    -225 Million USD
    Annual Net Income in USD
    -220 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Editas Medicine is a Biotechnology company. It is a genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. The company discover, develop, manufacture, and commercialize transformative, durable and precise genomic medicines for a broad class of diseases. The headquarters is in USA.
  2. Intersect Ent

    World Rank (Jan-05-2024)
    9,955
    World Rank (Jul-30-2023)
    9,955
    World Rank (Dec-25-2022)
    9,955
    World Rank (Jan-07-2022)
    9,955
    Market Cap (Jan-07-2022)
    0.91 Billion USD
    Annual Revenue in USD
    81 Million USD
    Annual Net Income in USD
    -72 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Intersect ENT is a Medical Technology company dedicated to advancing the treatment of ear, nose and throat conditions through evidence based innovation. The company annual revenue is approximately 109 million USD and 393 employees as on 2019. The headquarters is in USA.
  3. Revance Therapeutics

    World Rank (Jan-05-2024)
    9,978
    Market Cap (Jan-05-2024)
    0.772 Billion USD
    World Rank (Jul-30-2023)
    5,937
    Market Cap (Jul-30-2023)
    1.893 Billion USD
    World Rank (Dec-25-2022)
    6,247
    Market Cap (Dec-25-2022)
    1.613 Billion USD
    World Rank (Jan-07-2022)
    8,614
    Market Cap (Jan-07-2022)
    1.17 Billion USD
    Annual Revenue in USD
    132 Million USD
    Annual Operating Income in USD
    -272 Million USD
    Annual Net Income in USD
    -356 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Revance Therapeutics is a Biotechnology company. It is focused on innovative aesthetic and therapeutic offerings as well as financial technology services for aesthetic practices. It is having 193 employees as on 2019. The headquarters is in USA.
  4. REGENXBIO Inc.

    World Rank (Jan-05-2024)
    10,026
    Market Cap (Jan-05-2024)
    0.765 Billion USD
    World Rank (Jul-30-2023)
    9,791
    Market Cap (Jul-30-2023)
    0.818 Billion USD
    World Rank (Dec-25-2022)
    8,565
    Market Cap (Dec-25-2022)
    0.963 Billion USD
    World Rank (Jan-07-2022)
    8,285
    Market Cap (Jan-07-2022)
    1.25 Billion USD
    Annual Revenue in USD
    112 Million USD
    Annual Operating Income in USD
    -262 Million USD
    Annual Net Income in USD
    -280 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    REGENXBIO is a Clinical Stage Biotechnology company. The company currently developing gene therapy product candidates for the treatment of retinal, metabolic and neurodegenerative diseases and provide long lasting effects, potentially significantly altering the course of disease and delivering improved patient outcomes. The headquarters is in USA.
  5. Healthcare Services Group

    World Rank (Jan-05-2024)
    10,029
    Market Cap (Jan-05-2024)
    0.765 Billion USD
    World Rank (Jul-30-2023)
    9,122
    Market Cap (Jul-30-2023)
    0.927 Billion USD
    World Rank (Dec-25-2022)
    8,893
    Market Cap (Dec-25-2022)
    0.907 Billion USD
    World Rank (Jan-07-2022)
    8,019
    Market Cap (Jan-07-2022)
    1.32 Billion USD
    Annual Revenue in USD
    1,690 Million USD
    Annual Operating Income in USD
    53 Million USD
    Annual Net Income in USD
    35 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Healthcare Services Group is a Delivered Exceptional Housekeeping and Nutrition Services to an ever changing Healthcare Industry. It is having more than 45,000 employees and operating in 48 states. The headquarters is in USA.
  6. Tianjin Tianyao Pharmaceuticals

    World Rank (Jan-05-2024)
    10,051
    Market Cap (Jan-05-2024)
    0.761 Billion USD
    World Rank (Jul-30-2023)
    9,817
    Market Cap (Jul-30-2023)
    0.814 Billion USD
    World Rank (Dec-25-2022)
    10,275
    Market Cap (Dec-25-2022)
    0.709 Billion USD
    World Rank (Jan-07-2022)
    10,760
    Market Cap (Jan-07-2022)
    0.79 Billion USD
    Headquarters Country
  7. Zymeworks

    World Rank (Jan-05-2024)
    10,077
    Market Cap (Jan-05-2024)
    0.758 Billion USD
    World Rank (Jul-30-2023)
    13,171
    Market Cap (Jul-30-2023)
    0.467 Billion USD
    World Rank (Dec-25-2022)
    12,463
    Market Cap (Dec-25-2022)
    0.496 Billion USD
    World Rank (Jan-07-2022)
    11,722
    Market Cap (Jan-07-2022)
    0.66 Billion USD
    Annual Revenue in USD
    20 Million USD
    Annual Net Income in USD
    -162 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Zymeworks is a clinical Stage Biotechnology company. The company dedicated to the discovery, development, and commercialization of next generation multifunctional biotherapeutics initially focused on the treatment of cancer. The headquarters is in Canada.
  8. Retrophin

    World Rank (Jan-05-2024)
    10,171
    World Rank (Jul-30-2023)
    10,171
    World Rank (Dec-25-2022)
    10,171
    World Rank (Jan-07-2022)
    10,171
    Headquarters Country
    Company Profile
    Retrophin is a is a Biopharmaceutical company whose mission is to identify, develop and deliver life changing therapies to people living with rare disease. The company annual revenue is 185.3 million USD and 221 employees as on 2020. The headquarters is in USA.

Share

Ads